Cargando…
Is Patent “Evergreening” Restricting Access to Medicine/Device Combination Products?
BACKGROUND: Not all new drug products are truly new. Some are the result of marginal innovation and incremental patenting of existing products, but in such a way that confers no major therapeutic improvement. This phenomenon, pejoratively known as “evergreening”, can allow manufacturers to preserve...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4766186/ https://www.ncbi.nlm.nih.gov/pubmed/26910128 http://dx.doi.org/10.1371/journal.pone.0148939 |